Clinical Trial Update: A Cross-sectional Study of COPD and Symptom Variability in MEA Countries

View source ↗

Summary

AstraZeneca-conducted cross-sectional study across Middle East and Africa countries to assess symptom variability in chronic obstructive pulmonary disease. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease | Status: COMPLETED